These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19546530)

  • 1. Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.
    Cheng J; Zhang X; Zhang W; He Q; Tao X; Chen J
    Am J Nephrol; 2009; 30(4):315-22. PubMed ID: 19546530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials.
    Cheng J; Zhang W; Zhang XH; He Q; Tao XJ; Chen JH
    Int J Clin Pract; 2009 Jun; 63(6):880-8. PubMed ID: 19490198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of glucocorticoids for patients with IgA nephropathy: a meta-analysis.
    Qian G; Zhang X; Xu W; Zou H; Li Y
    Int Urol Nephrol; 2019 May; 51(5):859-868. PubMed ID: 30843135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ω-3 fatty acids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.
    Liu LL; Wang LN
    Clin Nephrol; 2012 Feb; 77(2):119-25. PubMed ID: 22257542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker therapy for IgA nephropathy: A meta-analysis of randomized controlled trials.
    Ji Y; Yang K; Xiao B; Lin J; Zhao Q; Bhuva MS; Yang H
    J Cell Biochem; 2019 Mar; 120(3):3689-3695. PubMed ID: 30270542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acids ameliorate proteinuria but not renal function in IgA nephropathy: a meta-analysis of randomized controlled trials.
    Chou HH; Chiou YY; Hung PH; Chiang PC; Wang ST
    Nephron Clin Pract; 2012; 121(1-2):c30-5. PubMed ID: 23095320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid for IgA Nephropathy: Are They Really Therapeutic?
    Lin Y; Jia J; Guo Y; He D; Zhang Y; Wang F; Yan T; Liu Y; Lin S
    Am J Nephrol; 2018; 47(6):385-394. PubMed ID: 29874651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials.
    Zhang Z; Yang Y; Jiang SM; Li WG
    BMC Nephrol; 2019 Aug; 20(1):333. PubMed ID: 31455248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic drug therapy for IgA nephropathy: a meta analysis of randomized controlled trials.
    Liu XJ; Geng YQ; Xin SN; Huang GM; Tu XW; Ding ZR; Chen XM
    Intern Med; 2011; 50(21):2503-10. PubMed ID: 22041349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis.
    Ravindran V; Rachapalli S; Choy EH
    Rheumatology (Oxford); 2009 Jul; 48(7):807-11. PubMed ID: 19447767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tacrolimus combined with glucocorticoid treatment for IgA nephropathy: a meta-analysis.
    Zhang Y; Luo J; Hu B; Ma T
    J Int Med Res; 2018 Aug; 46(8):3236-3250. PubMed ID: 29882450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive agents in the treatment of IgA nephropathy: A meta-analysis of clinical randomized controlled literature.
    Zheng J; Gong X; Wu Z
    Niger J Clin Pract; 2020 Apr; 23(4):437-449. PubMed ID: 32246648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune modulating therapy for IgA nephropathy: rationale and evidence.
    Floege J; Eitner F
    Semin Nephrol; 2008 Jan; 28(1):38-47. PubMed ID: 18222345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of the efficacy of transcatheter arterial chemoembolization combined with percutaneous ethanol injection in treating unresectable primary liver cancer].
    Gu GW; Li XC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):805-9. PubMed ID: 19595117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
    Tandon P; Rowe BH; Vandermeer B; Bain VG
    Am J Gastroenterol; 2007 Jul; 102(7):1528-36. PubMed ID: 17403073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy.
    Ding JX; Xu LX; Lv JC; Zhao MH; Zhang H; Wang HY
    Clin Immunol; 2007 Dec; 125(3):268-74. PubMed ID: 17913589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis.
    Xu G; Tu W; Jiang D; Xu C
    Am J Nephrol; 2009; 29(5):362-7. PubMed ID: 18974636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.
    Machado M; Cruz LS; Tannus G; Fonseca M
    Clin Ther; 2009 May; 31(5):962-79. PubMed ID: 19539097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of hydrotherapy in fibromyalgia syndrome--a meta-analysis of randomized controlled clinical trials.
    Langhorst J; Musial F; Klose P; Häuser W
    Rheumatology (Oxford); 2009 Sep; 48(9):1155-9. PubMed ID: 19608724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials.
    Mottillo S; Filion KB; Bélisle P; Joseph L; Gervais A; O'Loughlin J; Paradis G; Pihl R; Pilote L; Rinfret S; Tremblay M; Eisenberg MJ
    Eur Heart J; 2009 Mar; 30(6):718-30. PubMed ID: 19109354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.